Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/elbaCfbwocfCiKzthNdA

February 20, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Stories 
  • Okla. House committee passes anti-PBM bill
    An Oklahoma House panel passed a bill that would require pharmacy benefit managers to be licensed by the state pharmacy board and to disclose more operational information. If the bill is approved, it could result in higher drug prices for the state. "It provides pharmacists with competitive information that they otherwise wouldn't have. They can in turn raise prices," said PCMA spokesman Charles Coté. The Republic (Columbus, Ind.)/The Associated Press (2/19) LinkedInFacebookTwitterEmail this Story
  • Fla. House panel approves anti-biosimilars bill
    A Florida House subcommittee approved a bill that would require pharmacists to alert prescribing doctors when they substitute a biosimilar drug for a brand-name biologic drug and to keep records of biosimilar substitutions for four or more years. Opponents, including pharmacy benefit managers, pharmacists and some drugmakers, say the bill would stifle innovation, deny patients needed care and keep drug costs high. Sarasota Herald-Tribune (Fla.) (2/19) LinkedInFacebookTwitterEmail this Story
 Registration is now open for PCMA's Specialty Pharmacy Business Forum!
The SPBF provides individuals and companies in the specialty pharmacy chain of commerce with exceptional educational and business networking opportunities. A unique aspect of the conference is "PCMA-Connect," an online networking community that will give attendees the opportunity to search for, connect, and coordinate meetings with existing and potential business customers and partners.
 

  Legislative & Regulatory News 
  • Concerns grow about higher health insurance premiums under ACA
    Supporters of the Affordable Care Act are increasingly concerned that the law will lead to higher health insurance premiums, particularly for younger, healthier Americans, experts say. State regulators also are concerned that younger consumers will opt out of coverage, leaving the pool weighted toward older and sicker Americans whose premiums, under the law, are limited to three times those of younger participants. "The single biggest issue we face now is affordability," said Jill Zorn of the Universal Health Care Foundation of Connecticut. Los Angeles Times (tiered subscription model) (2/18) LinkedInFacebookTwitterEmail this Story
  • Group: Access to care would be hindered by Medicare Advantage cuts
    Reduced payments to Medicare Advantage plans will diminish seniors' access to care, America's Health Insurance Plans said. "Washington cannot tax and cut Medicare Advantage this much and not expect seniors to be harmed," AHIP President Karen Ignagni said in a statement. "These changes will disrupt coverage for Medicare Advantage beneficiaries at a time when evidence clearly demonstrates that Medicare Advantage provides higher-quality care than the fee-for-service part of Medicare." The Hill/Healthwatch blog (2/19) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  • More savings tied to higher use of generics, coverage gap's closure
    A study published in The American Journal of Managed Care found that having more patients use generics rather than brand-name treatments and closing the "doughnut hole" before 2020 would mean more savings for Medicare. Beneficiaries with schizophrenia or bipolar disorder whose access to treatment is uninterrupted are less likely to be admitted to hospitals, the study found. Lead author Kenneth Smith said policymakers should consider higher discounts on generics. USA Today (2/19) LinkedInFacebookTwitterEmail this Story
  SmartQuote 
We must travel in the direction of our fear."
--John Berryman,
American poet and scholar


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information